Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1974 2
1975 1
1976 1
1977 1
1978 1
1979 2
1980 1
1981 1
1982 2
1983 1
1984 1
1988 1
1991 1
1993 2
1995 1
1998 1
1999 1
2003 2
2004 6
2005 4
2006 4
2007 4
2008 2
2009 1
2010 1
2011 3
2012 6
2013 9
2014 11
2015 6
2016 11
2017 14
2018 20
2019 38
2020 47
2021 71
2022 24
Text availability
Article attribute
Article type
Publication date

Search Results

265 results
Results by year
Filters applied: . Clear all
Page 1
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Shannon S, Lewis N, Lee H, Hughes S. Shannon S, et al. Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041. Perm J. 2019. PMID: 30624194 Free PMC article.
CONTEXT: Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. ...Sleep scores improved within the first month in 48 patients (66.7%) but fluctuated over time. ...
CONTEXT: Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. ...Sleep scores improved within the first m …
Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Babson KA, Sottile J, Morabito D. Babson KA, et al. Curr Psychiatry Rep. 2017 Apr;19(4):23. doi: 10.1007/s11920-017-0775-9. Curr Psychiatry Rep. 2017. PMID: 28349316 Review.
Delta-9 tetrahydrocannabinol (THC) may decrease sleep latency but could impair sleep quality long-term. Novel studies investigating cannabinoids and obstructive sleep apnea suggest that synthetic cannabinoids such as nabilone and dronabinol may have short-ter …
Delta-9 tetrahydrocannabinol (THC) may decrease sleep latency but could impair sleep quality long-term. Novel studies investig …
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder.
de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL. de Almeida CMO, et al. Mov Disord. 2021 Jul;36(7):1711-1715. doi: 10.1002/mds.28577. Epub 2021 Mar 22. Mov Disord. 2021. PMID: 33754375 Clinical Trial.
BACKGROUND: REM sleep behaviour disorder (RBD) is a common non-motor feature of Parkinson's disease (PD). Cannabidiol (CBD) is one of the main non-psychoactive components of Cannabis sativa and may represent an alternative route for treating RBD. ...
BACKGROUND: REM sleep behaviour disorder (RBD) is a common non-motor feature of Parkinson's disease (PD). Cannabidiol ( …
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Crippa JA, et al. Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subjective effects of marijuana. Objectives: The aim of the present review is to describe the main advances in the development of the experiment …
Background: Among the many cannabinoids in the cannabis plant, cannabidiol (CBD) is a compound that does not produce the typical subj …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Bonaccorso S, et al. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. Neurotoxicology. 2019. PMID: 31412258 Review.
Cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. ...The initial search strategy identified some n = 1301 papers; n = 190 studies were included after the abstract's screening and n = 27 arti …
Cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. ...The …
Cannabidiol in sport: Ergogenic or else?
Gamelin FX, Cuvelier G, Mendes A, Aucouturier J, Berthoin S, Di Marzo V, Heyman E. Gamelin FX, et al. Pharmacol Res. 2020 Jun;156:104764. doi: 10.1016/j.phrs.2020.104764. Epub 2020 Mar 20. Pharmacol Res. 2020. PMID: 32205233 Review.
The few studies on physical exercise and cannabis focused on the main compound i.e. delta9-tetrahydrocannabinol. Cannabidiol (CBD) is another well-known phytocannabinoid present in dried or heated preparations of cannabis. ...Preclinical studies suggest that CBD could be u …
The few studies on physical exercise and cannabis focused on the main compound i.e. delta9-tetrahydrocannabinol. Cannabidiol (CBD) is …
Cannabis-based medicines for chronic neuropathic pain in adults.
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Mücke M, et al. Cochrane Database Syst Rev. 2018 Mar 7;3(3):CD012182. doi: 10.1002/14651858.CD012182.pub2. Cochrane Database Syst Rev. 2018. PMID: 29513392 Free PMC article. Review.
For efficacy, we calculated the number needed to treat for an additional beneficial outcome (NNTB) for pain relief of 30% and 50% or greater, patient's global impression to be much or very much improved, dropout rates due to lack of efficacy, and the standardised mean diff …
For efficacy, we calculated the number needed to treat for an additional beneficial outcome (NNTB) for pain relief of 30% and 50% or greater …
Cannabidiol as a suggested candidate for treatment of autism spectrum disorder.
Poleg S, Golubchik P, Offen D, Weizman A. Poleg S, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:90-96. doi: 10.1016/j.pnpbp.2018.08.030. Epub 2018 Aug 29. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30171992 Review.
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetitive patterns of behavior, interests, or activities and often intellectual disabilities. ASD has a number of prevalent co-morbidities, such as sleep disorde …
Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social communication, restricted and repetitive patterns of behavi …
The use of cannabinoids for sleep: A critical review on clinical trials.
Kuhathasan N, Dufort A, MacKillop J, Gottschalk R, Minuzzi L, Frey BN. Kuhathasan N, et al. Exp Clin Psychopharmacol. 2019 Aug;27(4):383-401. doi: 10.1037/pha0000285. Epub 2019 May 23. Exp Clin Psychopharmacol. 2019. PMID: 31120284
Sleep is often a secondary, rather than primary outcome in these studies. Many of the reviewed studies suggested that cannabinoids could improve sleep quality, decrease sleep disturbances, and decrease sleep onset latency. ...
Sleep is often a secondary, rather than primary outcome in these studies. Many of the reviewed studies suggested that cannabinoids co …
Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S, Kloiber S, Le Foll B. Elsaid S, et al. Prog Mol Biol Transl Sci. 2019;167:25-75. doi: 10.1016/bs.pmbts.2019.06.005. Epub 2019 Aug 28. Prog Mol Biol Transl Sci. 2019. PMID: 31601406 Review.
Cannabis sativa (cannabis) is one of the oldest plants cultivated by men. Cannabidiol (CBD) is the major non-psychomimetic compound derived from cannabis. ...Patients with Parkinson's disease (PD) have reported improvements in sleep and better quality of life …
Cannabis sativa (cannabis) is one of the oldest plants cultivated by men. Cannabidiol (CBD) is the major non-psychomimetic compound d …
265 results